Sign in
The Average Patient Does Not Enter Your Office: What Can We Learn About Treating nAMD From Individual Patient Responses
David S. Boyer, MD
Annual Meeting Talks
2019
BiWeekly Anti-VEGF Dosing for Chronic Refractory Neovascular Age-Related Macular Degeneration Unresponsive to Standard Monthly Dosing
Eric W Schneider, MD
Updates from the Field
Episode 11: Endophthalmitis after Intravitreal Anti-VEGF Injections with Dr. David Almeida
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Category: Pharmacology